Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Oruka Therapeutics, Inc. ORKA

Full chart Compare
Set alert

Price alert · ORKA

All alert types
102.86 USD +6.84 (+7.12%)

At closeNov 6, 2026, 5:42 PM EST

103.90 +1.04 +1.01%

After hours · Nov 6, 5:42 PM ET

96.05 Day range 103.75
26.38 52-week range 113.08
YTD
+239.36%
1 year
+263.72%

Financial health

Altman Z-Score

164.64 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 1

Valuation

P/E -13.1×
FY 2016: -1.6×FY 2017: -0.8×FY 2018: -0.6×FY 2019: -1.4×FY 2020: -5.7×FY 2021: -1.5×FY 2022: -3.4×FY 2023: -4.6×FY 2024: -3.9×FY 2025: -13.1×
FY 2016 5y median -3.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 2.9×
FY 2016: 1.2×FY 2017: 1.4×FY 2018: 0.8×FY 2019: 1.0×FY 2020: 4.9×FY 2021: 7.0×FY 2022: 9.8×FY 2023: 7.9×FY 2024: 0.9×FY 2025: 2.9×
FY 2016 5y median 7.0× FY 2025
P/FCF -15.6×
FY 2016: -1.7×FY 2017: -0.8×FY 2018: -0.6×FY 2019: -1.6×FY 2020: -29.3×FY 2021: -19.1×FY 2022: -37.6×FY 2023: 0.0×FY 2024: -5.6×FY 2025: -15.6×
FY 2016 5y median -15.6× FY 2025
EV/EBITDA -12.7×
FY 2016: -1.1×FY 2017: -0.3×FY 2018: 0.3×FY 2019: 0.1×FY 2020: -18.5×FY 2021: -15.9×FY 2022: -37.5×FY 2023: -49.1×FY 2024: -3.2×FY 2025: -12.7×
FY 2016 5y median -15.9× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -6.4%
FY 2016: -58.0%FY 2017: -124.1%FY 2018: -180.5%FY 2019: -63.7%FY 2020: -3.4%FY 2021: -5.2%FY 2022: -2.7%FY 2023: 0.0%FY 2024: -17.8%FY 2025: -6.4%
FY 2016 5y median -5.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -22.3%
FY 2016: -74.1%FY 2017: -180.0%FY 2018: -131.5%FY 2019: -72.0%FY 2020: -20.9%FY 2021: -37.9%FY 2022: -23.8%FY 2023: -14.4%FY 2024: -21.9%FY 2025: -22.3%
FY 2016 5y median -22.3% FY 2025
ROIC -25.8%
FY 2016: -74.7%FY 2017: -181.2%FY 2018: -134.1%FY 2019: -73.9%FY 2020: -20.8%FY 2021: -37.5%FY 2022: -23.4%FY 2023: -19.6%FY 2024: -23.0%FY 2025: -25.8%
FY 2016 5y median -23.4% FY 2025
ROA -21.6%
FY 2016: -66.8%FY 2017: -149.5%FY 2018: -116.2%FY 2019: -64.2%FY 2020: -19.3%FY 2021: -35.2%FY 2022: -23.0%FY 2023: -14.1%FY 2024: -21.1%FY 2025: -21.6%
FY 2016 5y median -21.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -38.5%
FY 2016: -45.0%FY 2017: -12.6%FY 2018: 56.6%FY 2019: 28.4%FY 2020: -68.0%FY 2021: -98.0%FY 2022: 49.1%FY 2023: 25.9%FY 2024: -1107.8%FY 2025: -38.5%
FY 2016 FY 2025
EPS (diluted) 53.7%
FY 2016: 0.5%FY 2017: 2.1%FY 2018: 67.7%FY 2019: 59.8%FY 2020: 83.1%FY 2021: -98.6%FY 2022: 50.4%FY 2023: 46.3%FY 2024: -12.4%FY 2025: 53.7%
FY 2016 FY 2025
Free Cash Flow -52.4%
FY 2016: -42.2%FY 2017: -16.5%FY 2018: 52.8%FY 2019: 41.7%FY 2020: -61.2%FY 2021: -142.8%FY 2022: 42.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -52.4%
FY 2016 FY 2025

Financial Health

Current Ratio 22.4×
FY 2016: 9.0×FY 2017: 5.9×FY 2018: 8.5×FY 2019: 9.2×FY 2020: 14.3×FY 2021: 15.6×FY 2022: 37.7×FY 2023: 59.0×FY 2024: 28.9×FY 2025: 22.4×
FY 2016 5y median 28.9× FY 2025
Quick Ratio 22.4×
FY 2016: 9.0×FY 2017: 5.9×FY 2018: 8.5×FY 2019: 9.2×FY 2020: 14.3×FY 2021: 15.6×FY 2022: 37.7×FY 2023: 59.0×FY 2024: 28.9×FY 2025: 22.4×
FY 2016 5y median 28.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 0.5×FY 2017: 0.5×FY 2018: 0.8×FY 2019: 1.5×FY 2020: 5.0×FY 2021: 2.7×FY 2022: 4.3×FY 2023: 7.1×FY 2024: 0.7×FY 2025: 0.4×
FY 2016 5y median 2.7× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -831×FY 2020: -1085×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -60.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 99.8%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -388.2%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31